Previous close | 69.10 |
Open | 69.25 |
Bid | 69.29 x 800 |
Ask | 69.32 x 900 |
Day's range | 68.87 - 69.67 |
52-week range | 56.58 - 72.81 |
Volume | 198,244 |
Avg. volume | 1,007,329 |
Market cap | 10B |
Beta (3Y monthly) | 0.78 |
PE ratio (TTM) | 20.89 |
EPS (TTM) | 3.31 |
Earnings date | 18 Feb 2020 - 24 Feb 2020 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 68.40 |
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Henry Schein and the National Council on Disability sign Memorandum of Understanding to improve access to care for Americans with disabilities.
Patterson Companies (PDCO) has likely gained from strength in Animal Health segment in the fiscal second quarter.
Henry Schein's (HSIC) suite of solutions, education, & social media activity featuring dental industry leaders to enable dental professionals to explore new options revolutionizing digital dentistry.
We'd be surprised if Henry Schein, Inc. (NASDAQ:HSIC) shareholders haven't noticed that an insider, Paul Brons...
Henry Schein (HSIC) registers solid performance across its key operating businesses in Q3.
Encouraging growth in the emerging markets despite the ongoing Sino-US trade tensions is likely to favor revenues in the medical products space this earnings season.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The robust performance of the Primescan system in Europe and the United States is expected to have contributed to Henry Schein's (HSIC) top line during Q3.
Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine and an upbeat third quarter 2019 view are likely to have contributed to Stryker's (SYK) Q3 earnings.
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investor confidence is still high on Henry Schein (HSIC), thanks to solid prospects.
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
In 1989 Stanley Bergman was appointed CEO of Henry Schein, Inc. (NASDAQ:HSIC). First, this article will compare CEO...
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.
Paylocity, Macy's, Henry Schein, DENTSPLY and Patterson Companies highlighted as Zacks Bull and Bear of the Day
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dental practice management software helps dental businesses run smoothly by ensuring safe storage and easy access of critical information.
The platform is expected to augment Henry Schein's (HSIC) patient revenues, accelerate payments and curb collection costs.
Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on...
Patterson Companies (PDCO) expects Dental and Animal Health arms to boost first-quarter fiscal 2020 results.
Let's see if Henry Schein (HSIC) stock is a good choice for value-oriented investors right now from multiple angles.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
HSIC earnings call for the period ending June 30, 2019.